Risk of psoriatic arthritis development with interleukin-17 inhibitors compared to tumour necrosis factor inhibitors

AN-PING HUOPUI-YING LEONGJAMES CHENG-CHUNG WEI2026-10-162026-10-162024-11-01Pure ID: 15396687Pure UUID: 744b679a-94fa-42b3-b62b-22ec481ab8d410.1016/j.ejim.2024.06.014https://www.scopus.com/pages/publications/85197491705https://scholars.csmu.edu.tw/handle/123456789/334093enRisk of psoriatic arthritis development with interleukin-17 inhibitors compared to tumour necrosis factor inhibitorsjournal article